MétaCan
Menu
← Back to cohort
Record W2064958261 · doi:10.1681/asn.2004110977

2004 Presidential Address

2005· article· en· W2064958261 on OpenAlexaboutno aff
William E. Mitch

Bibliographic record

VenueJournal of the American Society of Nephrology · 2005
Typearticle
Languageen
FieldMedicine
TopicDialysis and Renal Disease Management
Canadian institutionsnot available
Fundersnot available
KeywordsPresidential systemPresidential addressPolitical scienceMedicinePublic administrationLawPolitics

Abstract

fetched live from OpenAlex

It has been a singular honor to serve the American Society of Nephrology (ASN). Since my election to the council in 1988, our society has experienced tremendous growth in critical areas, including expanded involvement by ASN members in different activities of the society, in the breadth of educational programs, and in the ASN′s ability to address matters that directly affect our members and the patients for whom they provide medical care. Fortunately, the growth in ASN activities has occurred while the ASN Council (Table 1) has maintained its focus on promoting scientific developments in nephrology. In 1998, the president had two principal activities: (1) To ensure that the annual meeting contained the most exciting advances in nephrology research and (2) to improve the quality of educational programs centered on the practice of nephrology. These clinically based programs had been initiated as “Short Courses” by 1991 ASN president, Craig Tisher. Because of their popularity and their contributions to the practice of nephrology, clinical programs now occupy the first days of Renal Week and are incorporated throughout the meeting. Still, a principal activity of the president is to organize the ASN meeting by choosing a program director and committee that will continue the great tradition of presenting the most exciting scientific advances. This year’s program director, Jeff Sands, and the committee (Table 2) created a superb program that encompassed the enormous range of scientific interests of nephrologists. To name a few examples, the 2004 program contained new developments in understanding transport processes. Mechanisms by which water moves across cells was discussed by plenary lecturer Dr. Peter Agre, who shared the 2003 Nobel Prize in chemistry. Alfred Goldberg presented a plenary lecture about the ubiquitin-proteasome pathway and how it functions to present antigens and how certain cancers can be treated by inhibiting this pathway. The other plenary lectures were by Barbara Kahn, who discussed how malfunction of the adipocyte leads to type 2 diabetes, and by David Harrison, who described how intracellular oxidation reactions generate atherosclerosis. Besides providing an understanding of molecular events, these lectures covered major problems faced by the nephrologists who care for patients with chronic kidney disease. There also were symposia discussing basic and clinical advances in transplantation, which is especially noteworthy because 2004 is the 50th anniversary of the first successful kidney transplant. The 2004 Annual Meeting offered abundant educational opportunities addressing clinically important topics ranging from the diagnosis and management of patients with chronic kidney disease to advances in interventional nephrology, to vascular biology; there also was a 2-d session for those planning to certify or recertify in nephrology based on American Board of Internal Medicine requirements. These sessions plus clinical nephrology conferences held throughout the meeting were created by the ASN Postgraduate Education Committee (Table 3). Besides clinical symposia, there were two dinner sessions for ASN attendees who are interested in the basic sciences. Goals of the ASN The ASN charter indicates that our society was organized “to enhance and assist the study and practice of nephrology; to provide a forum for the promulgation of research; and to meet the professional and continuing education needs of its members.” In 2003, another purpose was added: “To become the leading professional organization in nephrology.” This is a daunting task because of the range of interests of ASN members, but two items are required to accomplish this goal. First, the ASN must be in position to influence funding and public policy that could affect research, education, and patient care. Second, there must be meaningful input from ASN members to identify areas that should be addressed and a means by which members can provide ideas and talent to solve problems. How has the ASN attempted to fulfill these two requirements? To quote Winston Churchill, “However beautiful the strategy, you should occasionally look at the results.” Active participation of ASN members occurs at several levels: First, advisory committees have been created to provide ideas and leadership in specific areas of interest, including acute renal failure, basic science and clinical science, clinical practice, chronic kidney disease, dialysis, hypertension, policy and public affairs, and transplantation. Second, one of the ASN councilors (Table 1) participates in each ASN activity and reports on the goals and accomplishments of the group to the council, but activities of these advisory committees must be organized so that issues impacting the science and clinical practice of nephrology are addressed effectively. To create such an organization, the ASN Council and 2003 president, Norman J. Siegel, formed the ASN Board of Advisors (BOA). The BOA consists of chairs of the different advisory groups and committees (Table 4). At Renal Week 2003, the first meeting was held, and it quickly became apparent that we had tapped into the ideas and talents of enthusiastic members who were committed to solving problems affecting nephrology. For example, the Practicing Nephrologists Advisory Group, represented by Drs. Arnold Berns and Joan Blondin, pointed out important issues are affecting clinical practice and suggested the ASN should address these issues. Besides offering strategies to address these problems, they suggested how the ASN regional meetings (see below) could be improved. An excellent example of BOA committee activities and how groups work together is the response of the ASN Policy & Public Affairs and Dialysis Committees to new regulations about practice guidelines for dialysis patients. At Renal Week 2003, a session was devoted to reviewing Center for Medicare/Medicaid Services (CMS) regulations that mandate weekly examinations of dialysis patients. This year, CMS is considering methods of adjusting physician payments based on patient outcomes. In dealing with this proposal, Jonathan Himmelfarb, representing the Dialysis Advisory Committee; Don Wesson, representing our Policy and Public Affairs Committee; Paul Smedberg, the ASN Director of Policy and Public Affairs; and Councilor Bill Henrich met with CMS leaders. After a full examination of the pros and cons of the new CMS proposals, the group submitted official comments about physician fee schedules and the proposed guidelines for monitoring erythropoietin dosing as well as the impact of the Medicare Advantage Program on ESRD patients. This group in conjunction with National Kidney Foundation (NKF) President, Brian Periera, also wrote a “white paper.” This document provides a full analysis of issues that should be solved before regulations linking physician payments to patient outcomes are established and was published in the December issue of the Journal of the American Society of Nephrology (JASN). The paper shows how advisory committees, the council, and the ASN staff can function to deal quickly and effectively with problems that face nephrology and ASN members. Addressing this problem included the full participation of our sister organization, the NKF, represented by Brian Periera, NKF president. In addition, a semifinal draft of the paper was shared with the Renal Physicians Association as they were preparing a response to CMS proposals. Finally, this white paper is important not only because it addresses serious issues that impact the practice of nephrology but it also could influence other clinical practices because CMS decisions about payments to nephrologists frequently serve as the basis for how CMS and medical insurance companies deal with physicians providing other medical services. In short, the ASN has been at the forefront in addressing an important issue in clinical nephrology. As a final example of ASN activities, the FDA asked the ASN to comment about the use of an ultrafiltration machine designed to remove fluid from patients with congestive heart failure. The ASN Dialysis Advisory Committee responded quickly using the expertise of members with extensive experience with extracorporeal devices and submitted a critique of the CHF Solutions System 100 machine. They also worked with the manufacturers to improve the safety of this type of therapy. ASN Membership The St. Louis arch, the “Gateway to the West,” indirectly applies to the ASN to function as a gateway to nephrology (Figure 1). For example, the ASN charter indicates that an active ASN member is “any person holding the degree of M.D. or Ph.D., or its equivalent, who has demonstrated a major and continuing interest in nephrology and who is a resident of a country of North or Central America shall be eligible for membership in the Society.” To meet the intent of our charter, Tomas Berl, 2005 ASN president, and I developed a program for nephrologists in Central America and the Caribbean area by working with the leadership of Sociedad Latinoamericana de Nefrologia y Hipertension (SLANH). Our goal is to incorporate young Latin American nephrologists or nephrology trainees into ASN activities. With the help of a grant, the young nephrologist spends the month preceding Renal Week working in a nephrology division in the United States or Canada followed by attending Renal Week. The program is jointly funded by the ASN and SLANH, and nephrology divisions in the United States and Canada have enthusiastically supported a program to host a young Latin American nephrologist. The program will be reviewed yearly to ascertain how it affects the careers of the young nephrologists. During our meetings with the leaders of SLANH, we learned that this program would be very popular with young nephrologists throughout Latin America. Although we plan to emphasize participation by nephrologists from Central America and the Caribbean, we agree with SLANH leadership that colleagues from other Latin American countries could participate, and, not unexpected, there are 2004 grantees from Argentina and Brazil (Table 5). Our plan is to promote interest in the science and practice of nephrology while bringing advances in our discipline to others living and working in our hemisphere. In a related development, the council decided to extend ASN membership to colleagues outside North American as long as they are members of their local/national nephrology society. These new “e-members” will have the privileges of ASN membership including JASN and Nephrology Self-Assessment Program (NephSAP) but will receive publications electronically. Colleagues in the Australian-New Zealand Nephrology Society as well as members of SLANH have expressed interest in this program, and we expect that these interactions will make our society even stronger. The other category of members is nephrology fellows. They are designated as associate members and receive JASN and NephSAP gratis from the ASN. ASN Educational Activities The submission of 4100 abstracts and our attendance of 10,996 colleagues to Renal Week 2004 indicates that we are fulfilling the goal of the ASN charter to provide a forum for advancing research, but this is not where efforts to meet the educational requirements end: As PGE director Bob Narins likes to say, the Annual Board Review Course has become a “right of passage” for many fellows. Approximately 25% of the Board Review Course participants attend to gain an update in nephrology while the rest of the participants are preparing for the examination. A new program, the regional meetings, deserves special emphasis. These meetings last 1.5 d and are directed at bringing the highlights of Renal Week to colleagues who could not attend the ASN meeting or missed certain sessions of interest plus those who want a concise review of Renal Week highlights. Last year, the program was held in New York City, Chicago, and Los Angeles and was enthusiastically received; in January and February of 2005, regional meetings will be enlarged to include three new cities: Washington, DC; Seattle; and Dallas (see asn-online.org). Besides educational meetings, the ASN has several publications (Table 6). With the able leadership of editor Bill Couser and deputy editor Allison Eddy, JASN has maintained the highest ranking among all nephrology publications. Besides nephrology fellows, JASN is sent to nephrology units in the developing world as part of the Library Enhancement Program of the International Society of Nephrology. Our other publication, NephSAP, is edited by Dick Glassock and provides a readable and intensive review of different nephrology topics; it also provides CME credit. I confess that some of the questions are a bit abstruse, but Dick tells me this just requires more homework! Renal Express and Renal Policy Express are electronically transmitted information about national and governmental issues that affect nephrology. Paul Smedberg, Director of Policy and Public Affairs, uses this instrument to keep ASN members informed of important changes in public policy. Many of you know that the ASN will begin “self publication” in 2005 because it will allow the ASN more latitude to craft ways to interact with the membership. This also allows growth in publications. Based on recommendations from the BOA and many members, the council voted to create a new clinical journal. Approximately 50% of this journal will be devoted to publishing peer-reviewed clinical investigation and 50% to educational material. The search committee for an editor of the new clinical journal is chaired by Bill Henrich with a tentative initial publication in 2006. ASN and Research Nephrologists and their patients have benefited greatly from the remarkable advances that have occurred in nephrology. These advances have arisen in large part from the increase in funding that has doubled the National Institutes of Health (NIH) budget. What has been the role of the ASN? In 1988, ASN scientists in conjunction with the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) leadership convened a research retreat with the goal of defining areas in nephrology that were ripe for clinical investigation or areas that needed more attention to understand the mechanisms underlying different disorders. The Renal Disease Research Plan (Figure 2) resulted from this meeting and has been used by the NIDDK leadership to plan research strategies. This plan, however, was published almost 6 yr ago, so the council decided to reconvene research retreats but with a more focused strategy. The strategy was to adopt principles of the NIH Roadmap and emphasize “cross cutting” themes that would involve disciplines from epidemiology to basic science. Listed on the right side of Figure 2 are the five areas that were chosen to be the focus of intensive research retreats. Each conference will produce a white paper that identifies specific research goals and formulates new investigative strategies. Besides scientists and clinical investigators, there has been participation by the leaders of NIDDK and input from the National Heart, Lung, and Blood Institute and the National Institute of Allergy and Infectious Diseases. Their involvement is important because the five research conferences will identify critical research areas in kidney disease for the institutes. We believe this will be useful because projected budgets do not include the same generous increases for the NIH. During Renal Week, Dr. Allen Spiegel, Director of the NIDDK, discussed new research directions for the NIH and emphasized the far-reaching changes that are taking place at the NIH based on the NIH Roadmap. He explained the emphasis on integrating expertise from several disciplines and the goal of achieving cross-institute collaboration and funding potential. Budgetary of the NIH are a major of for ASN members and nephrology The ASN has addressed this in several the council with leaders of NIDDK and the and to programs so that will be used to continue the remarkable of providing into the of kidney and for Second, the ASN to include in the NIH that NIDDK to create for for the study of clinical of kidney disease. In addition, the NIH the National Heart, Lung, and Blood Institute to with the NIDDK to study the impact of kidney disease and especially Finally, Paul has been to the Committee of for Research while the ASN to promote research in the Renal and the Council of American Kidney What other activities has the ASN to nephrology a few ago, the in conjunction with NIDDK the Kidney Diseases The goal was to the by providing to address clinically important The would be to a analysis of a clinical problem including mechanisms of disease or strategies. There have been Kidney Diseases and have been a These have resulted in several research and programs are for other of the ASN and Research Finally, there is the critical problem of funding scientific in nephrology. Although the ASN make for NIH funding the council that our society should advances in the and of kidney This year, the ASN was to more in and the plan is to increase funding even more (Figure 3). The funding for the of young to to scientists (Table for several of these is shared by other The Kidney and Foundation of America and the ASN funding of the Research the American Society of and ASN funding of the the Association of and the ASN the in and the Foundation and the ASN a to study Besides these the ASN established who are the focus of their research and medical who plan to study nephrology. The are reviewed by the ASN Review Committee (Table and by other ASN members on an information about ASN can be at the of these requires as the are from The council that should be funded of and has a Committee to strategies to create a Research The committee consists of Bob and They have developed a plan that will new while to create a Research our goal is to nephrology research in a Finally, a new program was initiated last year, the of ASN members as American Society of Nephrology This program is and more have been The ASN staff is the for this and we will be The is for yr and leaders in basic or clinical research, clinical nephrology, or renal The requirements are in each JASN issue and are present on requires Board and CME We believe that these requirements are important because the ASN is the first medical society to promote continuing education and After nephrologists meeting these requirements are more to in their medical As changes for colleagues who have been of the ASN. I would to the many contributions of Dr. Program Director of Nephrology in the of and Diseases (Figure 4). Although was for nephrology also many of who were of kidney disease. I help I was and a problem with a was for the of the and me that would be a very make I know that many of you had the same and I for and three members of our society this It is with that we some of their many Norman was the who was committed to patient care (Figure 5). He and the basis for understanding the clinical of and water by the and group was the first to document the of to renal This the to the of acute As of Medicine at of Medicine from to Dr. was as a who was committed to patient care and scientific as of the Institute of Committee to study the Medicare ESRD program and issues about were for nephrology. as president of the ASN in and as president of the International Society of Nephrology from to (Figure 6). With the ASN′s in Besides these Dr. as for Health Affairs, was in of Medicine to but many of will Dr. as a of and for to promoting the careers of young As a was the of the clinical (Figure about the of and were of In of Dr. the David of Medicine for and to the of In addition, and the 2003 from the ASN for contributions to nephrology and clinical practice and patient care. a colleagues and patients will and and have a lecture in It will be presented this by Dr. this I that it a of we This is addressed by the council, and I that we can and will make for at two First, we have an organization created by a very and enthusiastic staff who are devoted to the goals of the society. The group is by our very director, Dr. Second, it has been very to how ASN members have in to address important issues in nephrology. I you will agree we are attention to Winston that strategies must be The to the in St. Louis is of the role of the American Society of Nephrology in new in of research developed by the American Society of Nephrology in and and proposed funding for research by the American Society of Dr. the National Institutes of Health and is a of many members of the American Society of Dr. Norman was a superb and while how physicians should the highest of medical Dr. the growth of nephrology and the careers of many young Dr. was a clinical who to provide the patient ASN Council 2004 Program 2004 Postgraduate Education Board of 2004 2004 ASN 2004 ASN 2004 ASN Review Committee

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.004
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesInsufficient payload (model declined to judge)
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Not applicable · Consensus signal: Not applicable
GenreCandidate signal: Editorial · Consensus signal: none
Teacher disagreement score0.595
Threshold uncertainty score0.578

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0010.004
Meta-epidemiology (narrow)0.0010.000
Meta-epidemiology (broad)0.0010.001
Bibliometrics0.0010.001
Science and technology studies0.0020.000
Scholarly communication0.0060.002
Open science0.0010.002
Research integrity0.0050.004
Insufficient payload (model declined to judge)0.5950.573

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.013
GPT teacher head0.283
Teacher spread0.270 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

Study designNot applicable
Domainnot available
GenreEditorial

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2005
Admission routes1
Has abstractyes

Explore more

Same venueJournal of the American Society of Nephrology→Same topicDialysis and Renal Disease Management→French-language works237,207→